Abstract:Using an immunogenic nonmetastatic murine mammary adenocarci- noma (Dl-DMBA-3) induced in BALB/c mice by dimethylbenzanthra- cene, we have previously shown that splenocytes from tumor bearers have depressed lymphocyte responses to mitogens and antigens, including tumor-associated antigens. In addition, they display decreased natural killer and T-cell cytotoxic activities. Macrophages from tumor-bearing mice appear to be responsible for the suppression of T- and B-cell responses to concanavalin A, lipopolysaccharide, and tumor-associated antigens observed in tumor bearers. The appearance of these macro phages in the spleen tightly parallels the progressive growth of the tumor and the concomitant immunosuppression. Simultaneously high levels of macrophage progenitors were observed in blood, bone marrow, lung, and liver. A significant increase of colony-stimulating activity of the granu- locyte-macrophage lineage was detected in the sera from tumor-bearing mice. Higher levels of this colony-stimulating activity (CSA) were de tected in tumor cystic fluid as compared with the levels in serum. A tumor cell line established in vitro from the Dl-DMBA-3 in vivotumor produces high levels of a factor with CSA in culture supernatant fluids. Partial purification of the CSA from the tumor cell line supernatants was achieved using Centriceli Ultrafiltration and Sephacryl S-300 chromatog- raphy. These studies revealed that the molecular weight of the colony- stimulating-like factor is 32,000 to 35,000. The morphology of the colonies obtained in cultures using this factor is similar to that of the colonies that develop in the presence of granulocyte-macrophage colony- stimulating factor (GM-CSF) but not with macrophage colony-stimulat ing factor (M-CSF). CSA from tumor cell supernatants was neutralized by antiserum to GM-CSF but not with anti-M-CSF or anti-granulocyte colony-stimulating factor (G-CSF). Macrophages from bone marrow or peritoneal exÃºdalesfrom normal mice cultured with tumor supernatant for 2 to 3 days strongly inhibit normal splenocyte responses to concana valin A and lipopolysaccharide. The data suggest that the tumor releases a GM-CSF that alters the hemopoietic system and induces or expands macrophages, which exert a suppressive function on the immune system of tumor-bearing mice. presser functions appear to play important roles in the regulation of a great variety of in vivo and in vitro immunolog- ical phenomena (1-7). Exactly how those cells are induced and/ or expanded in the tumor-bearing host has not been clearly elucidated. Moreover, it is not known whether tumor products and/or host products directly or indirectly cause the observed immunosuppression. Using an immunogenic nonmetastatic murine mammary ad- enocarcinoma induced in BALB/c mice by dimethylbenzan- thracene (Dl-DMBA-3), we have previously observed a gener alized immunosuppressed state as determined by diminished proliferative responses to mitogens and antigens, decreased natural killer and cytolytic T-lymphocyte activities, and other criteria (8-11). In addition, there is an induction of macro phages in the spleen of tumor bearers which have a Mac 1*2+ phenotype. These macrophages appear to be responsible for the observed immunosuppression via various mechanisms, which include release of prostaglandins and aberrant presentation of antigens in the context of I-E molecules to T-suppressor cells (12). An investigation was undertaken to elucidate the mecha nism of induction of these suppressor macrophages that are in the spleens of mammary tumor-bearing mice. In this paper we present evidence that there is a systemic increase of granulocyte and macrophage progenitors associated with an elevated col ony-stimulating activity in the serum and tumor cystic fluid of tumor bearers. Furthermore, supernatants of tumor cells grown in vitro release high levels of GM-CSF' as defined by bioassays, biochemistry, and neutralization with antiserum to this factor. The results indicate that the tumor constitutively produces GM- CSF, which induces cells of the macrophage lineage that alters nonspecific and specific immune responses in tumor-bearing mice.

Effect of Active Immunization Against a Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor/somatostatin Fusion Protein on the Growth of Mice

Effect of Immunization with a Recombinant Cholera Toxin B Subunit/somatostatin Fusion Protein on Immune Response and Growth Hormone Levels in Mice

Can 29kda Rhgm-Csf Expressed by Silkworm Pupae Bioreactor Bring into Effect As Active Cytokine Through Orally Administration?

The Effects and Mechanisms of GM-CSF on Endometrial Regeneration

Effect of Ginsenoside Rg1 on Immune Efficacy of P30 Fusion Protein of Toxoplasma Gondii in Mice

The Anti-Tumor Immune Responses Induced by a Fusion Protein of Ovarian Carcinoma Anti-Idiotypic Antibody 6b11scfv and Murine GM-CSF in BALB/c Mice

Humoral Immune Responses Induced By Anti-Idiotypic Antibody Fusion Protein Of 6b11scfv/Hgm-Csf In Balb/C Mice

Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.

Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia Pastoris.

A Study on Enhanced Anti-Tumor Immunity Induced by High Level Expression of GM-CSF in 3LL Tumor Site of the Mice

Effect of GM-CSF on the T Helper Cell Response Induced by Gene Immunization with Antigenized Antibody

Enhanced Immune Response to Foot-and-mouth Disease Vaccine by Oral Administration of Ginseng Stem-Leaf Saponins

Effect of Bcl-2 Gene Immunization on Growth and Growth Hormone of Mice

Immune Responses of M-Csf-r Dna Vaccine and Its Effects on Hematopoiesis in Mice

Expansion Of Immunoregulatory Macrophages By Granulocyte-Macrophage Colony-Stimulating Factor Derived From A Murine Mammary-Tumor

[Immunoregulation Effects in Vitro of the Xenoprotein in Combination with Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor and Bacillus Calmette-Guerin].

Protective Effects of Recombinant Human Granulocyte Macrophage Colony Stimulating Factor on H1N1 Influenza Virus-Induced Pneumonia in Mice.

Effects of granulocyte-macrophage colony stimulating factor gene encoded vaccinia virus vector on murine pulmonary metastatic melanoma

Therapeutic Efficacy of Bifidobacterium Longum-Mediated Human Granulocyte Colony-Stimulating Factor And/Or Endostatin Combined with Cyclophosphamide in Mouse-Transplanted Tumors

Comparison of fusion protein and DC vaccine in inhibition of mouse B16F10 melanoma tumor

Ag85B Synergizes with ESAT-6 to Induce Efficient and Long-Term Immunity of C57BL/6 Mice Primed with Recombinant Bacille Calmette-Guerin.